AIC
ATRS

Ameritas Investment Company’s Antares Pharma, Inc. ATRS Stock Holding History

Ameritas Investment Company’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100
Closed – – 1621
2019
Q3 		$0 Buy
+100
New +$329 ﹤0.01% 1672
2019
Q1 		– Sell
-7,000
Closed -$19K – 1918
2018
Q4 		$19K Buy
+7,000
New +$23.1K ﹤0.01% 902

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Ameritas Investment Company's ATRS Position: Q4 2019 in Review

Ameritas Investment Company sold out of Antares Pharma, Inc. (ATRS) in Q4 2019, closing a stake of 100 shares.

Ameritas Investment Company first reported a position in ATRS in Q4 2018 and held it in 2 quarters. The position peaked at $19K in Q4 2018. 160 funds tracked by Wall St. Rank hold ATRS as of Q4 2019.

  • Ameritas Investment Company reported no remaining Antares Pharma, Inc. position as of Q4 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 100 Antares Pharma, Inc. shares in Q4 2019.
  • Ameritas Investment Company first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Antares Pharma, Inc. position peaked at $19K in Q4 2018.
  • 160 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2019.

Based on Ameritas Investment Company's 13F filing for Q4 2019, filed 18 Feb 2020.